Avecho Biotechnology

Avecho Biotechnology Limited (AVE , formerly Phosphagenics Limited) develops and commercialises Human and Animal Health products using its proprietary drug delivery system called TPM (Targeted Penetration Matrix).

Contact Details

Unit A8, Hallmarc Business Park , 2A Westall Rd CLAYTON VIC 3168

03 9002 5000

info@avecho.com.au

www.avecho.com.au

Lists and Charts

Share price

Avecho Biotechnology
Closing price for the last 90 trading days

View ASX Chart

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
413^th	Energy World Corporation	33.33%	-24.15%
414^th	Babylon Pump & Power	33.33%	-15.89%
415^th	Avecho Biotechnology	33.33%	5.92%
416^th	Perpetual Resources	33.33%	-14.97%
417^th	Zenith Energy	33.3%	24.15%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Company Share Transactions

Company Activity

	NEW ROLE: Katherine(Kathy) Connell, Non-Executive Director	11 Jul 2024
	NEW ROLE: Roksan Libinaki, General Manager	24 Nov 2020
	NEW ROLE: Anna Legg, Former Chief Financial Officer/Secretary	24 Nov 2020
	NEW ROLE: Alex Stojanovic, Vice President - Business Development & Commercial Operations	24 Nov 2020
	NEW ROLE: Matt McNamara, Non-Executive Director	03 Nov 2020
	NEW ROLE: Melanie Leydin, Chief Financial Officer, Company Secretary	03 Nov 2020
	NEW ROLE: Paul Gavin, Chief Executive Officer	03 Nov 2020
	NEW ROLE: Greg Collier, Non-Executive Chairman, Non-Executive Director	03 Nov 2020
	NEW ROLE: David Segal, Non-Executive Director	03 Nov 2020

Related Information

Access to our data for Avecho Biotechnology is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Avecho Biotechnology is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today